HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$27.98
Day range
$25.62 - $28.14
Year range
$2.86 - $29.51
Market cap
2.04B USD
Avg Volume
5.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.88M | 21.95% |
Net income | -42.22M | -22.17% |
Net profit margin | — | — |
Earnings per share | -0.49 | 18.33% |
EBITDA | -45.83M | -22.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 328.96M | 53.17% |
Total assets | 352.45M | 53.13% |
Total liabilities | 44.96M | 43.83% |
Total equity | 307.49M | — |
Shares outstanding | 68.66M | — |
Price to book | 6.25 | — |
Return on assets | -31.23% | — |
Return on capital | -34.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -42.22M | -22.17% |
Cash from operations | -34.53M | -27.80% |
Cash from investing | 17.27M | -62.38% |
Cash from financing | 41.00K | -55.43% |
Net change in cash | -17.21M | -190.61% |
Free cash flow | -15.46M | -11.96% |
About
Founded
2006
Headquarters
Website
Employees
122
